Application 202231
- Type
- NDA
- Sponsor
- FRESENIUS KABI USA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | POWDER;INTRAVENOUS | 100MCG/VIAL | Yes | Yes |
| 002 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | POWDER;INTRAVENOUS | 200MCG/VIAL | Yes | Yes |
| 003 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | POWDER;INTRAVENOUS | 500MCG/VIAL | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N202231-001 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 |
| N202231-002 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 |
| N202231-003 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 500MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N202231-001 | AP |
| N202231-002 | AP |
| N202231-003 | AP |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N202231-001 | 9168238 | 2032-08-29 | Drug product | 2015-10-28 | |
| N202231-001 | 9168239 | 2032-08-29 | Drug product | 2015-10-28 | |
| N202231-001 | 9006289 | 2032-10-03 | Drug product | 2015-04-14 | |
| N202231-002 | 9168238 | 2032-08-29 | Drug product | 2015-10-28 | |
| N202231-002 | 9168239 | 2032-08-29 | Drug product | 2015-10-28 | |
| N202231-002 | 9006289 | 2032-10-03 | Drug product | 2015-04-14 | |
| N202231-003 | 9168238 | 2032-08-29 | Drug product | 2015-10-28 | |
| N202231-003 | 9168239 | 2032-08-29 | Drug product | 2015-10-28 | |
| N202231-003 | 9006289 | 2032-10-03 | Drug product | 2015-04-14 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N202231-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N202231-002 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N202231-003 | LEVOTHYROXINE SODIUM | 500MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N202231-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N202231-002 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N202231-003 | LEVOTHYROXINE SODIUM | 500MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N202231-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N202231-002 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N202231-003 | LEVOTHYROXINE SODIUM | 500MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N202231-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N202231-002 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N202231-003 | LEVOTHYROXINE SODIUM | 500MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N202231-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N202231-002 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N202231-003 | LEVOTHYROXINE SODIUM | 500MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N202231-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N202231-002 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N202231-003 | LEVOTHYROXINE SODIUM | 500MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N202231-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N202231-002 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N202231-003 | LEVOTHYROXINE SODIUM | 500MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N202231-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N202231-002 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N202231-003 | LEVOTHYROXINE SODIUM | 500MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N202231-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N202231-002 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N202231-003 | LEVOTHYROXINE SODIUM | 500MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N202231-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N202231-002 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N202231-003 | LEVOTHYROXINE SODIUM | 500MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N202231-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N202231-002 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N202231-003 | LEVOTHYROXINE SODIUM | 500MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N202231-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N202231-002 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N202231-003 | LEVOTHYROXINE SODIUM | 500MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N202231-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N202231-002 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N202231-003 | LEVOTHYROXINE SODIUM | 500MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N202231-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2011-06-24 | 1e350fbaab3a… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N202231-001 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N202231-002 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N202231-003 | AP | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N202231-001 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N202231-002 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N202231-003 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N202231-001 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N202231-002 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N202231-003 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N202231-001 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N202231-002 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N202231-003 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N202231-001 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N202231-002 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N202231-003 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N202231-001 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N202231-002 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N202231-003 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N202231-001 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N202231-002 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N202231-003 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N202231-001 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N202231-002 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N202231-003 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N202231-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N202231-002 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N202231-003 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N202231-001 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N202231-002 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N202231-003 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N202231-001 | AP | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N202231-002 | AP | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N202231-003 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N202231-001 | AP | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N202231-002 | AP | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N202231-003 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N202231-001 | AP | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N202231-002 | AP | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N202231-003 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N202231-001 | AP | 1 | 1e350fbaab3a… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N202231-001 | 9168238 | 2032-08-29 | Drug product | 2015-10-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N202231-001 | 9168239 | 2032-08-29 | Drug product | 2015-10-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N202231-001 | 9006289 | 2032-10-03 | Drug product | 2015-04-14 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N202231-002 | 9168238 | 2032-08-29 | Drug product | 2015-10-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N202231-002 | 9168239 | 2032-08-29 | Drug product | 2015-10-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N202231-002 | 9006289 | 2032-10-03 | Drug product | 2015-04-14 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N202231-003 | 9168238 | 2032-08-29 | Drug product | 2015-10-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N202231-003 | 9168239 | 2032-08-29 | Drug product | 2015-10-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N202231-003 | 9006289 | 2032-10-03 | Drug product | 2015-04-14 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N202231-001 | 9168238 | 2032-08-29 | Drug product | 2015-10-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N202231-001 | 9168239 | 2032-08-29 | Drug product | 2015-10-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N202231-001 | 9006289 | 2032-10-03 | Drug product | 2015-04-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N202231-002 | 9168238 | 2032-08-29 | Drug product | 2015-10-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N202231-002 | 9168239 | 2032-08-29 | Drug product | 2015-10-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N202231-002 | 9006289 | 2032-10-03 | Drug product | 2015-04-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N202231-003 | 9168238 | 2032-08-29 | Drug product | 2015-10-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N202231-003 | 9168239 | 2032-08-29 | Drug product | 2015-10-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N202231-003 | 9006289 | 2032-10-03 | Drug product | 2015-04-14 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N202231-001 | 9168238 | 2032-08-29 | Drug product | 2015-10-28 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N202231-001 | 9168239 | 2032-08-29 | Drug product | 2015-10-28 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N202231-001 | 9006289 | 2032-10-03 | Drug product | 2015-04-14 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N202231-002 | 9168238 | 2032-08-29 | Drug product | 2015-10-28 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N202231-002 | 9168239 | 2032-08-29 | Drug product | 2015-10-28 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N202231-002 | 9006289 | 2032-10-03 | Drug product | 2015-04-14 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N202231-003 | 9168238 | 2032-08-29 | Drug product | 2015-10-28 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N202231-003 | 9168239 | 2032-08-29 | Drug product | 2015-10-28 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N202231-003 | 9006289 | 2032-10-03 | Drug product | 2015-04-14 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N202231-001 | 9168238 | 2032-08-29 | Drug product | 2015-10-28 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N202231-001 | 9168239 | 2032-08-29 | Drug product | 2015-10-28 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N202231-001 | 9006289 | 2032-10-03 | Drug product | 2015-04-14 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N202231-002 | 9168238 | 2032-08-29 | Drug product | 2015-10-28 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N202231-002 | 9168239 | 2032-08-29 | Drug product | 2015-10-28 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N202231-002 | 9006289 | 2032-10-03 | Drug product | 2015-04-14 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N202231-003 | 9168238 | 2032-08-29 | Drug product | 2015-10-28 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N202231-003 | 9168239 | 2032-08-29 | Drug product | 2015-10-28 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N202231-003 | 9006289 | 2032-10-03 | Drug product | 2015-04-14 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N202231-001 | 9168238 | 2032-08-29 | Drug product | 2015-10-28 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N202231-001 | 9168239 | 2032-08-29 | Drug product | 2015-10-28 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N202231-001 | 9006289 | 2032-10-03 | Drug product | 2015-04-14 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N202231-002 | 9168238 | 2032-08-29 | Drug product | 2015-10-28 | fd3edfee7708… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM ANHYDROUS | ENDO USA, Inc. | 9d815416-11c9-470e-a82f-89b0bf232e12 | 2025-04-28 | Boxed warning, Warnings, Adverse reactions | 202231 NDA202231 42023-203 42023-202 42023-201 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM ANHYDROUS | Fresenius Kabi USA, LLC | ce990712-49c1-4f66-9ee4-c770e8ec394c | 2025-04-17 | Boxed warning, Warnings, Adverse reactions | 202231 NDA202231 63323-647 63323-648 63323-649 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM ANHYDROUS | Fresenius Kabi USA, LLC | 152d071f-d4aa-46d2-b397-61c1cabdd86d | 2024-10-14 | Boxed warning, Warnings, Adverse reactions | 202231 NDA202231 63323-648 63323-649 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM ANHYDROUS | Fresenius Kabi USA, LLC | f88f44d8-2f18-4155-9d78-6323d19fbafe | 2024-10-14 | Boxed warning, Warnings, Adverse reactions | 202231 NDA202231 63323-649 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 42023-201 | Levothyroxine Sodium | LEVOTHYROXINE SODIUM ANHYDROUS | Par Pharmaceutical Inc. | NDA | Current |
| 42023-201 | Levothyroxine Sodium | LEVOTHYROXINE SODIUM ANHYDROUS | Par Pharmaceutical Inc. | NDA | Current |
| 42023-201 | Levothyroxine Sodium | LEVOTHYROXINE SODIUM ANHYDROUS | Par Pharmaceutical Inc. | NDA | Current |
| 42023-202 | Levothyroxine Sodium | LEVOTHYROXINE SODIUM ANHYDROUS | Par Pharmaceutical Inc. | NDA | Current |
| 42023-202 | Levothyroxine Sodium | LEVOTHYROXINE SODIUM ANHYDROUS | Par Pharmaceutical Inc. | NDA | Current |
| 42023-202 | Levothyroxine Sodium | LEVOTHYROXINE SODIUM ANHYDROUS | Par Pharmaceutical Inc. | NDA | Current |
| 42023-203 | Levothyroxine Sodium | LEVOTHYROXINE SODIUM ANHYDROUS | Par Pharmaceutical Inc. | NDA | Current |
| 42023-203 | Levothyroxine Sodium | LEVOTHYROXINE SODIUM ANHYDROUS | Par Pharmaceutical Inc. | NDA | Current |
| 42023-203 | Levothyroxine Sodium | LEVOTHYROXINE SODIUM ANHYDROUS | Par Pharmaceutical Inc. | NDA | Current |
| 63323-647 | Levothyroxine Sodium | LEVOTHYROXINE SODIUM ANHYDROUS | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-647 | Levothyroxine Sodium | LEVOTHYROXINE SODIUM ANHYDROUS | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-648 | Levothyroxine Sodium | LEVOTHYROXINE SODIUM ANHYDROUS | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-648 | Levothyroxine Sodium | LEVOTHYROXINE SODIUM ANHYDROUS | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-648 | Levothyroxine Sodium | LEVOTHYROXINE SODIUM ANHYDROUS | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-648 | Levothyroxine Sodium | LEVOTHYROXINE SODIUM ANHYDROUS | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-649 | Levothyroxine Sodium | LEVOTHYROXINE SODIUM ANHYDROUS | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-649 | Levothyroxine Sodium | LEVOTHYROXINE SODIUM ANHYDROUS | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-649 | Levothyroxine Sodium | LEVOTHYROXINE SODIUM ANHYDROUS | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-649 | Levothyroxine Sodium | LEVOTHYROXINE SODIUM ANHYDROUS | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-649 | Levothyroxine Sodium | LEVOTHYROXINE SODIUM ANHYDROUS | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-649 | Levothyroxine Sodium | LEVOTHYROXINE SODIUM ANHYDROUS | Fresenius Kabi USA, LLC | NDA | Current |
| 66794-647 | Levothyroxine Sodium | Levothyroxine Sodium | Piramal Critical Care, Inc. | NDA AUTHORIZED GENERIC | Current |
| 66794-647 | Levothyroxine Sodium | Levothyroxine Sodium | Piramal Critical Care, Inc. | NDA AUTHORIZED GENERIC | Current |
| 66794-648 | Levothyroxine Sodium | Levothyroxine Sodium | Piramal Critical Care, Inc. | NDA AUTHORIZED GENERIC | Current |
| 66794-648 | Levothyroxine Sodium | Levothyroxine Sodium | Piramal Critical Care, Inc. | NDA AUTHORIZED GENERIC | Current |
| 66794-649 | Levothyroxine Sodium | Levothyroxine Sodium | Piramal Critical Care, Inc. | NDA AUTHORIZED GENERIC | Current |
| 66794-649 | Levothyroxine Sodium | Levothyroxine Sodium | Piramal Critical Care, Inc. | NDA AUTHORIZED GENERIC | Current |